Weight loss drug Zepbound is now available, says Eli Lilly
CNN – This was announced by the drug manufacturer Eli Lilly Tuesday that its flagship weight loss drug, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, was approved by the US Food and Drug Administration to treat type 2 diabetes called Mounjaro. Last month, the FDA approved it for use in chronic … [Read more…]